Search Results
Adil Daud - Recent Developments in the treatment of Melanoma
"Meet the Researcher" - Dr. Adil Daud, co-Director of the UCSF Melanoma Program
Dr. Daud on Dabrafenib/Trametinib Vs Immunotherapy in Melanoma
Dr. Daud on Challenges Facing the Treatment Landscape for Melanoma
Dr. Daud on the Combinations of Immunotherapy for Melanoma
Adil Daud, MD: Optimal Sequencing for BRAF-Mutant Melanoma Patients
Dr. Daud on the Challenges of Treating Metastatic Melanoma With BRAF Inhibitor Monotherapy
How to Navigate a Metastatic Diagnosis Dr. Adil Daud and Dr. Justin Moser.
Melanoma Patient Symposium, 2022
Dr. Daud Discusses the Immunogenicity of Melanoma
Immunotherapy Options and Side Effect Management for Advanced/Metastatic Melanoma
Challenges Facing the Field of Melanoma
